Sign In
Buy ICCC
$11.21
+0.150 (+1.36%)
At Close: Jul 31, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC
06:42pm, Thursday, 02'nd Sep 2021
New York, New York--(Newsfile Corp. - September 2, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation ("ImmuCell" or the "Company") (NASDAQ: ICCC). Such inves
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC
07:18pm, Wednesday, 25'th Aug 2021
New York, New York--(Newsfile Corp. - August 25, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation ("ImmuCell" or the "Company") (NASDAQ: ICCC). Such inves
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC
07:29pm, Tuesday, 24'th Aug 2021
NEW YORK, Aug. 24, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ImmuCell Corporation ("ImmuCell" or the "Company") (NASDAQ: ICCC). Such investors are ad
ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®
06:30am, Tuesday, 24'th Aug 2021
PORTLAND, Maine, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2021 Results - Earnings Call Transcript
11:45am, Friday, 13'th Aug 2021
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2021 Results - Earnings Call Transcript
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
04:05pm, Thursday, 12'th Aug 2021
Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000) Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000)
ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021
06:30am, Thursday, 05'th Aug 2021
Conference Call Scheduled for Friday, August 13, 2021 at 9:00 AM ET Conference Call Scheduled for Friday, August 13, 2021 at 9:00 AM ET
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2021 Results - Earnings Call Transcript
11:52am, Friday, 14'th May 2021
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2021 Results - Earnings Call Transcript
ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021
01:41pm, Thursday, 06'th May 2021
Conference Call Scheduled for Friday, May 14, 2021 at 9:00 AM ET Conference Call Scheduled for Friday, May 14, 2021 at 9:00 AM ET
ImmuCell Closes $4,250,000 Equity Financing
05:15pm, Wednesday, 14'th Apr 2021
PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021
08:00am, Wednesday, 07'th Apr 2021
PORTLAND, Maine, April 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2020 Results - Earnings Call Transcript
10:17am, Tuesday, 23'rd Feb 2021
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2020 Results - Earnings Call Transcript
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020
01:42pm, Tuesday, 16'th Feb 2021
Conference Call Scheduled for Tuesday, February 23, 2021 at 9:00 AM ET Conference Call Scheduled for Tuesday, February 23, 2021 at 9:00 AM ET
ImmuCell Announces Restructuring of its Bank Debt
04:05pm, Tuesday, 15'th Dec 2020
PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q3 2020 Results - Earnings Call Transcript
01:43pm, Friday, 13'th Nov 2020
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q3 2020 Results - Earnings Call Transcript
